Assessment of Structural Brain Changes Related to Anoxic Coma Using High-field and Very Low Field Mobile MRI
CUBE
2 other identifiers
interventional
60
1 country
1
Brief Summary
Standard predictors of outcome after cardiac arrest (CA) have substantial limitations in terms of reliability and generalizability. By providing brain structural connectivity maps, or connectomes, advanced MRI techniques, operating through high-strength magnetic field (HF; 1.5 to 3-T), have precisely revealed white and grey brain matter damages induced by CA, and have demonstrated the high sensitivity and specificity of these indicators for predicting neurological outcome after CA. However, HF MRI requires rigid safety precautions, highly trained technicians and patient transport to dedicated hospital imaging suites, hindering the implementation of these promising neuroimaging techniques in the setting of critical illness. Interestingly, a recent report demonstrates the capability of a proof-of-concept very low-field (VLF; 0.064-T) mobile MRI to obtain neuroimaging at the bedside in critically ill patients. Nevertheless, the spatial resolution of VLF-MRI seems low and there is no available evidence about the use of VLF-MRI to extract highly needed new predictors of neurological recovery based on critical brain structural connectomes. The CUBE project holds the promise of providing a radical paradigm shift in the field of neuroprognostication of anoxic coma patients. The current proposal is a "proof-of concept" study which aims to compare for the first time, HF, VLF and enhanced VLF (recon-VLF) structural connectomes from anoxic coma patients and healthy subjects across the time (3 paired HF and VLF brain scan across the first two weeks after CA). To obtain recon-VLF data, the Investigators will use an ensemble of ground-breaking methods to increase the native spatial resolution of VLF-MRI data. The whole brain imaging dataset will be used to prepare future neuroprognostication studies based on fully bedside assessment of brain structural integrity after CA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedFirst Posted
Study publicly available on registry
September 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2029
September 17, 2025
September 1, 2025
3 years
May 20, 2025
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences between whole-brain white (WWM-FA) and grey (GMM) matter global metrics independently acquired by HF and VLF-MRI scans very early after coma onset (D0)
White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes. Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes. Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).
Day 0
Secondary Outcomes (9)
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-scores.
Day 0
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score
Day 7
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score
Day 15
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
day 0
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
day 7
- +4 more secondary outcomes
Study Arms (2)
Comatose patients after anoxic brain injury
EXPERIMENTALComatose patients after anoxic brain injury Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset
Healthy volunteers
OTHERHealthy volunteers Adult patients matched in age (plus or minus 5 years) and gender to patients
Interventions
MRI will be early acquired, as soon as possible after patient hospital admission and always in coma state for patients. For both patients and controls each MRI scanning session will encompass pairs of HF and VLF MRI acquisitions, that will be collected the same day. The main MRI sequences will be: T1, T2, FLAIR and DWI. The VLF spatial resolution recommended by the constructor for all these sequences correspond to voxel size is around 1.5mm/1.5mm/5mm. The total brain scanning time is estimated at 30 minutes.
Eligibility Criteria
You may qualify if:
- COMA PATIENTS
- Adult patients (male or female ≥ 18 years).
- Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset.
- Written informed consent from patient's legal representative.
- Affiliation to the French social security system
- HEALTHY VOLUNTEERS
- Adult patients (male or female ≥ 18 years).
- Written informed consent.
- Affiliation to the French social security system
You may not qualify if:
- COMA PATIENTS
- Brain death.
- Coma explained by other cause than CA.
- Pregnancy.
- MRI contraindication: medical material not MRI compatible.
- Hemodynamic instability or respiratory failure precluding patient's transport and MRI scanning.
- HEALTHY VOLUNTEERS
- Pregnancy.
- MRI contraindication: medical material not MRI compatible.
- Volunteers who do not wish to be informed of an abnormality detected on MRI a posteriori
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Toulouse
Toulouse, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2025
First Posted
September 17, 2025
Study Start
September 15, 2025
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
March 1, 2029
Last Updated
September 17, 2025
Record last verified: 2025-09